ZYDUSLIFEPharmaceuticals
Zydus Lifesciences Ltd — PE Ratio & Valuation Analysis
₹871.20
+0.00%
Current P/E18.74xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E22.8x17.7% below avg
✅
41.0% Discount to Industry
ZYDUSLIFE P/E 18.74x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹44.97 | ₹914 | 20.3x |
| 2024 | ₹38.14 | ₹972 | 25.5x |
| 2023 | ₹19.30 | ₹689 | 35.7x |
| 2022 | ₹43.83 | ₹420 | 9.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Zydus Lifesciences Ltd Valuation
Zydus Lifesciences Ltd (ZYDUSLIFE) currently trades at 18.74x earnings. The Pharmaceuticals sector average PE is 31.77x. ZYDUSLIFE is trading at a discount to peers — may indicate relative value. Historically, ZYDUSLIFE has traded at an average PE of 22.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
21.21%
Dividend Yield
1.17%
More on Zydus Lifesciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.